iShares Nasdaq Biotechnology (IBB)

Add to Watchlists
Create an Alert
271.95 +0.02  +0.01% NASDAQ Dec 6, 10:59 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

Expense Ratio 0.47%
Share Class Assets Under Management 7.764B
30-Day Average Daily Volume Upgrade
Net Asset Value 270.54
Discount or Premium to NAV -0.03%
Turnover Ratio 24.00

IBB Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV) Cat. Total Return (Price) % Rank in Cat. (Price)
1M 8.04% -- 25 -- 34
3M -3.06% -- 29 -- 30
6M -3.40% -- 54 -- 35
1Y -17.90% -- 91 -- 75
3Y 7.06% -- 67 -- 55
5Y 22.03% -- 8 -- 11
As of Dec. 2, 2016
Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.11% 0.11% 0.00
Stock 99.89% 99.89% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Nov. 30, 2016

IBB Region Exposure

Americas 97.99%
North America 97.99%
Latin America 0.00
Greater Europe 1.41%
United Kingdom 0.54%
Europe Developed 0.69%
Europe Emerging 0.00
Africa/Middle East 0.19%
Greater Asia 0.60%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.60%
Market Classification
% Developed Markets 99.40%
% Emerging Markets 0.60%
As of Nov. 30, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Nov. 30, 2016

IBB Stock Market Capitalization

Giant 24.25%
Large 37.18%
Medium 14.52%
Small 12.98%
Micro 11.06%
As of Nov. 30, 2016

IBB Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 14.36%
Large Cap Growth 50.64%
Mid Cap Value 1.07%
Mid Cap Blend 0.95%
Mid Cap Growth 13.35%
Small Cap Value 1.36%
Small Cap Blend 3.46%
Small Cap Growth 14.81%
As of Nov. 30, 2016
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
CELG Celgene Corp 9.28% 117.38 +0.70%
BIIB Biogen Inc 8.04% 291.91 +0.58%
GILD Gilead Sciences Inc 7.86% 72.29 -0.10%
AMGN Amgen Inc 7.08% 144.88 -0.28%
REGN Regeneron Pharmaceuticals Inc 7.07% 367.50 -0.63%
ALXN Alexion Pharmaceuticals Inc 4.07% 124.34 -0.47%
MYL Mylan NV 3.61% 35.35 -0.84%
VRTX Vertex Pharmaceuticals Inc 3.61% 77.09 +2.04%
INCY Incyte Corp 3.55% 106.74 +1.89%
ILMN Illumina Inc 3.31% 125.89 -1.59%
As of Nov. 30, 2016
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 0.55 yrs
Diane Hsiung 8.84 yrs
Greg Savage 8.84 yrs
Jennifer Hsui 4.25 yrs

IBB Net Fund Flows

1M 654.57M
3M 926.19M
6M 1.454B
YTD 1.591B
1Y 1.129B
3Y 3.027B
5Y 4.170B
10Y 3.434B
As of Nov. 30, 2016

IBB Risk Info

Beta 1.344
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.6838
Historical Sortino (All) 0.5224
30-Day Rolling Volatility 35.34%
Daily Value at Risk (VaR) 1% (All) 4.85%
Monthly Value at Risk (VaR) 1% (All) 19.78%

IBB Fundamentals

Dividend Yield TTM (12-6-16) 0.16%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 19.90
Weighted Average Price to Sales Ratio 5.730
Weighted Average Price to Book Ratio 4.469
Weighted Median ROE 14.23%
Weighted Median ROA -0.49%
Forecasted Dividend Yield 0.33%
Forecasted PE Ratio 19.67
Forecasted Price to Sales Ratio 4.992
Forecasted Price to Book Ratio 3.458
Number of Holdings 182
As of Nov. 30, 2016

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 12.55%
Forecasted Book Value Growth 25.77%
Forecasted Cash Flow Growth 40.69%
Forecasted Earnings Growth 29.53%
Forecasted Revenue Growth 16.04%
As of Nov. 30, 2016

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2016
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.